Prostate Cancer Survivorship Monitoring
What is Prostate Cancer Survivorship Monitoring?
Prostate cancer survivorship monitoring is the ongoing health tracking you need after finishing prostate cancer treatment. This includes surgery, radiation, hormone therapy, or active surveillance. The goal is to catch any cancer recurrence early and manage long-term side effects from treatment.
Regular blood tests measure your prostate-specific antigen, or PSA, levels to detect signs of returning cancer. PSA is a protein made by prostate tissue. Even after your prostate is removed, small amounts of PSA may remain from residual tissue. Rising PSA levels can signal cancer coming back before symptoms appear.
Survivorship care focuses on staying healthy for the long term. This means monitoring for recurrence, managing treatment side effects, and preventing new health problems. Most prostate cancer survivors need monitoring for many years, sometimes for life. Regular testing helps you stay ahead of problems and maintain your quality of life.
Symptoms
- Rising PSA levels on blood tests without other symptoms
- Bone pain or fractures, especially in the back, hips, or ribs
- Difficulty urinating or weak urine stream
- Blood in urine or semen
- Erectile dysfunction or changes in sexual function
- Unexplained weight loss or fatigue
- Swelling in legs or pelvic area
- New urinary incontinence or leaking
Many survivors have no symptoms when cancer returns. PSA blood tests often detect recurrence months or years before you feel anything wrong. This is why regular monitoring matters even when you feel healthy.
Concerned about Prostate Cancer Survivorship Monitoring? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Prostate cancer can return because microscopic cancer cells survived initial treatment. These cells may stay dormant for years before growing again. Recurrence risk depends on your original cancer stage, grade, and PSA level at diagnosis. Higher-risk cancers are more likely to come back even after aggressive treatment.
Treatment type affects your monitoring needs. Men who had surgery typically have very low PSA levels afterward, so any rise is concerning. Men treated with radiation may have higher baseline PSA that decreases slowly. Hormone therapy can suppress PSA temporarily, but levels may rise when treatment stops. Age, genetics, lifestyle factors, and overall health also influence long-term outcomes and second cancer risk.
How it's diagnosed
Prostate cancer survivorship monitoring relies primarily on regular PSA blood tests. Your doctor will order free PSA testing, which measures both total PSA and the percentage that circulates freely in your blood. Testing frequency depends on your cancer risk level and time since treatment. High-risk survivors may need testing every 3 to 6 months initially, then annually if stable.
Rite Aid offers convenient PSA monitoring through our add-on blood panel. You can get tested at over 2,000 Quest Diagnostics locations nationwide without waiting for a doctor appointment. Rising PSA levels trigger additional testing like imaging scans or biopsies. Your care team uses PSA trends over time, not single results, to make decisions about recurrence.
Treatment options
- Regular PSA blood tests every 3 to 12 months based on risk level
- Digital rectal exams during follow-up appointments with your urologist or oncologist
- Imaging scans like CT, MRI, or bone scans if PSA rises or symptoms develop
- Hormone therapy to suppress testosterone and slow cancer growth if recurrence occurs
- Radiation therapy for localized recurrence after surgery
- Salvage surgery in select cases of radiation treatment failure
- Lifestyle changes including plant-based diet, regular exercise, and weight management
- Pelvic floor exercises and medications for urinary incontinence
- ED medications or devices for sexual function problems
- Vitamin D and calcium supplements to protect bone health during hormone therapy
Need testing for Prostate Cancer Survivorship Monitoring? Add it to your panel.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Testing frequency depends on your cancer risk and treatment type. High-risk survivors typically need PSA tests every 3 to 6 months for the first few years, then annually if results stay stable. Low-risk survivors may only need testing once or twice yearly. Your oncologist will create a personalized monitoring schedule based on your specific situation.
After radical prostatectomy, PSA should drop to undetectable levels below 0.1. Two consecutive readings above 0.2 usually indicate biochemical recurrence. After radiation therapy, PSA nadir varies, but a rise of 2.0 or more above the lowest point suggests recurrence. Your doctor looks at PSA trends over time, not just single numbers.
Yes, healthy habits may lower recurrence risk and improve outcomes. Eat mostly plants with limited red meat and dairy. Exercise at least 150 minutes weekly with both cardio and strength training. Maintain a healthy weight, as obesity increases recurrence risk. Avoid smoking and limit alcohol to support immune function and overall health.
Common lasting effects include urinary incontinence, erectile dysfunction, bowel problems, and fatigue. Hormone therapy can cause hot flashes, bone loss, muscle weakness, and metabolic changes. Regular monitoring helps catch complications like osteoporosis, heart disease, or diabetes early. Many side effects improve with time or respond well to treatment.
Yes, active surveillance requires close monitoring to ensure cancer remains low-risk. You typically need PSA tests every 3 to 6 months plus periodic biopsies. This strategy works for slow-growing cancers but demands strict adherence to testing schedules. Rising PSA or changing biopsy results may prompt a switch to active treatment.
Rising PSA triggers additional evaluation to determine if cancer has returned. Your doctor may order imaging scans like PSMA PET, MRI, or bone scans to locate recurrence. Treatment depends on where cancer appears and may include radiation, hormone therapy, or both. Early detection of recurrence through PSA monitoring improves treatment success.
Yes, Rite Aid offers convenient PSA monitoring through our add-on blood panel. You can visit any of over 2,000 Quest Diagnostics locations for testing. Results are shared with you and can be forwarded to your care team. This makes staying on schedule easier without frequent specialist visits.
Talk to your doctor before starting any supplements. Vitamin D and calcium help protect bone health, especially during hormone therapy. Some survivors benefit from omega-3 fatty acids for heart health. Avoid high-dose supplements like vitamin E or selenium unless deficient, as evidence for cancer prevention is mixed.
Most survivors need lifelong PSA monitoring because late recurrences can happen decades after treatment. Testing may become less frequent if PSA stays undetectable for many years. Guidelines recommend monitoring intervals based on your risk level, but you should never completely stop surveillance. Long-term tracking also helps detect second primary cancers.
Digital rectal exams assess for local recurrence or new abnormalities. Testosterone levels are monitored if you receive hormone therapy. Bone density scans check for osteoporosis from androgen deprivation. Blood counts and metabolic panels track treatment side effects. Imaging studies are added when PSA rises or symptoms develop.